Search research articles
Contact Us
Filters
Showing results (111-120 of 171) with videos related to
Page
of 18
Sort By:
Journal of Neuro-Oncology
|
July 27, 2011
The toxicity of intrathecal bevacizumab in a rabbit model of leptomeningeal carcinomatosis
Priscilla K Brastianos, Harry C Brastianos, Wesley Hsu, et al.
Neuro-Oncology
|
July 10, 2010
A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma
Myrna R Rosenfeld, Marc C Chamberlain, Stuart A Grossman, et al.
Neuro-Oncology
|
February 11, 2004
Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: final report of NABTT 97-11
Tracy T Batchelor, Mark R Gilbert, Jeffrey G Supko, et al.
Oncoimmunology
|
June 15, 2018
Systemic depletion of lymphocytes following focal radiation to the brain in a murine model
Anna F Piotrowski, Thomas R Nirschl, Esteban Velarde, et al.
Journal of Neuro-Oncology
|
March 10, 2010
Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma
Surasak Phuphanich, Jeffrey G Supko, Kathryn A Carson, et al.
Journal of Neuro-Oncology
|
December 3, 2015
The effect of regadenoson-induced transient disruption of the blood-brain barrier on temozolomide delivery to normal rat brain
Sadhana Jackson, Nicole M Anders, Antonella Mangraviti, et al.
Neurosurgery
|
October 7, 2020
A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma
David M Peereboom, Xiaobu Ye, Tom Mikkelsen, et al.
Journal of Neuro-Oncology
|
November 28, 2023
A multi-site phase I trial of Veliparib with standard radiation and temozolomide in patients with newly diagnosed glioblastoma multiforme (GBM)
Lawrence Kleinberg, Xiaobu Ye, Jeff Supko, et al.
Neuro-Oncology Advances
|
July 9, 2024
Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy in patients with newly diagnosed glioblastoma
Samuel Ryu, Xiaobu Ye, Jeffrey J Olson, et al.
Oncotarget
|
February 9, 2018
Phase II study of rituximab given in conjunction with standard chemotherapy in primary central nervous system lymphoma (PCNSL): a trial of the ECOG-ACRIN cancer research group (E1F05)
Lode J Swinnen, Anne O'Neill, Philip H Imus, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 171) with videos related to
Sort By:
Page
of 18
Journal of Neuro-Oncology
|
July 27, 2011
The toxicity of intrathecal bevacizumab in a rabbit model of leptomeningeal carcinomatosis
Priscilla K Brastianos, Harry C Brastianos, Wesley Hsu, et al.
Neuro-Oncology
|
July 10, 2010
A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma
Myrna R Rosenfeld, Marc C Chamberlain, Stuart A Grossman, et al.
Neuro-Oncology
|
February 11, 2004
Phase 2 study of weekly irinotecan in adults with recurrent malignant glioma: final report of NABTT 97-11
Tracy T Batchelor, Mark R Gilbert, Jeffrey G Supko, et al.
Oncoimmunology
|
June 15, 2018
Systemic depletion of lymphocytes following focal radiation to the brain in a murine model
Anna F Piotrowski, Thomas R Nirschl, Esteban Velarde, et al.
Journal of Neuro-Oncology
|
March 10, 2010
Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma
Surasak Phuphanich, Jeffrey G Supko, Kathryn A Carson, et al.
Journal of Neuro-Oncology
|
December 3, 2015
The effect of regadenoson-induced transient disruption of the blood-brain barrier on temozolomide delivery to normal rat brain
Sadhana Jackson, Nicole M Anders, Antonella Mangraviti, et al.
Neurosurgery
|
October 7, 2020
A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma
David M Peereboom, Xiaobu Ye, Tom Mikkelsen, et al.
Journal of Neuro-Oncology
|
November 28, 2023
A multi-site phase I trial of Veliparib with standard radiation and temozolomide in patients with newly diagnosed glioblastoma multiforme (GBM)
Lawrence Kleinberg, Xiaobu Ye, Jeff Supko, et al.
Neuro-Oncology Advances
|
July 9, 2024
Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy in patients with newly diagnosed glioblastoma
Samuel Ryu, Xiaobu Ye, Jeffrey J Olson, et al.
Oncotarget
|
February 9, 2018
Phase II study of rituximab given in conjunction with standard chemotherapy in primary central nervous system lymphoma (PCNSL): a trial of the ECOG-ACRIN cancer research group (E1F05)
Lode J Swinnen, Anne O'Neill, Philip H Imus, et al.
Page
of 18